who owns the patent for semaglutide Ozempic's problem: how Novo Nordisk lost control of a blockbuster drug. π Demand GLP-1 weight-loss drugs has exploded, turning Ozempic into a $40bn+ revenue engine for Novo Nordisk. But, despite Aspen Pharmacare wins Canada approval
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours Β· Estimated delivery Aug 12 - Aug 17













:max_bytes(150000):strip_icc()/VWH-GettyImages-2276706586.jpg-4e49ad1f948143ed99767b89bf0289d7.jpg)









